Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
6
×
life sciences
national blog main
national top stories
new york top stories
boston blog main
boston top stories
fda
new york blog main
drugs
san francisco top stories
biotech
indiana blog main
indiana top stories
national
new york
roche
san diego blog main
san diego top stories
san francisco blog main
abbvie
acorda therapeutics
allergan
allopregnanolone
amgen
ampyra
apokyn
apomorphine
billy dunn
biogen
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brexanolone
bristol-myers squibb
calcitonin gene-related peptide
cancer
chronic migraine
clinical data
What
approved
6
×
drug
6
×
new
6
×
fda
medicine
disease
friday
late
oks
patients
acorda
announced
approval
atrophy
brexanolone
cancer
class
cope
daily
data
decision
deeper
depression
devastating
developed
disorder
dna
eli
episodes
evrysdi
fast
fatty
fingerprint
genetic
gets
going
green
headache
help
home
Language
unset
Current search:
approved
×
drug
×
" clinical trials "
×
new
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines